CD47 Blockade Triggers T cell-mediated Destruction of Immunogenic Tumors

Although previous work indicated that the antitumor effects of anti-CD47 require macrophage phagocytosis of tumor cells, new work done in immunocompetent mice bearing syngeneic tumors reveals a key role for dendritic cell cross-priming of CD8+ T cells.